Related references
Note: Only part of the references are listed.In vitro activity of several antimicrobial peptides against colistin-susceptible and colistin-resistant Acinetobacter baumannii
X. Vila-Farres et al.
CLINICAL MICROBIOLOGY AND INFECTION (2012)
In Vivo Efficacy of Glycopeptide-Colistin Combination Therapies in a Galleria mellonella Model of Acinetobacter baumannii Infection
M. Hornsey et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Synergistic Killing of Multidrug-Resistant Pseudomonas aeruginosa at Multiple Inocula by Colistin Combined with Doripenem in an In Vitro Pharmacokinetic/Pharmacodynamic Model
Phillip J. Bergen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Phosphoethanolamine Modification of Lipid A in Colistin-Resistant Variants of Acinetobacter baumannii Mediated by the pmrAB Two-Component Regulatory System
Alejandro Beceiro et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Carbapenem-Resistant Enterobacteriaceae: Epidemiology and Prevention
Neil Gupta et al.
CLINICAL INFECTIOUS DISEASES (2011)
In vitro activity of teicoplanin combined with colistin versus multidrug-resistant strains of Acinetobacter baumannii
D. W. Wareham et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Discovery research: the scientific challenge of finding new antibiotics
David M. Livermore
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Epidemiology of Infections Acquired in Intensive Care Units
Joseph S. Doyle et al.
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Multiresistant Gram-negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance
Neil Woodford et al.
FEMS MICROBIOLOGY REVIEWS (2011)
A Novel Polymyxin Derivative That Lacks the Fatty Acid Tail and Carries Only Three Positive Charges Has Strong Synergism with Agents Excluded by the Intact Outer Membrane
Martti Vaara et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Mass Balance and Pharmacokinetics of [14C]Telavancin following Intravenous Administration to Healthy Male Volunteers
Jeng-Pyng Shaw et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Proteus mirabilis pmrI, an RppA-Regulated Gene Necessary for Polymyxin B Resistance, Biofilm Formation, and Urothelial Cell Invasion
Sin-Sien Jiang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Potent Synergy and Sustained Bactericidal Activity of a Vancomycin-Colistin Combination versus Multidrug-Resistant Strains of Acinetobacter baumannii
N. C. Gordon et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Multiresistant Gram-negative infections: a global perspective
Jennifer Ho et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2010)
Multidrug-resistant Acinetobacter baumannii: mechanisms of virulence and resistance
Nicola C. Gordon et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
Combination testing of multidrug-resistant cystic fibrosis isolates of Pseudomonas aeruginosa: use of a new parameter, the susceptible breakpoint index
K. E. N. Milne et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Randomized controlled trial of nebulized colistimethate sodium as adjunctive therapy of ventilator-associated pneumonia caused by Gram-negative bacteria
Pinyo Rattanaumpawan et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Effectiveness and safety of colistin: prospective comparative cohort study
Mical Paul et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Postantibiotic Effects of Telavancin against 16 Gram-Positive Organisms
G. A. Pankuch et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Telavancin Disrupts the Functional Integrity of the Bacterial Membrane through Targeted Interaction with the Cell Wall Precursor Lipid II
Christopher S. Lunde et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Wasp Mastoparans Follow the Same Mechanism as the Cell-Penetrating Peptide Transportan 10
Lindsay E. Yandek et al.
BIOCHEMISTRY (2009)
Novel polymyxin derivatives carrying only three positive charges are effective antibacterial agents
Martti Vaara et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Telavancin versus vancomycin for the treatment of complicated skin and skin-structure infections caused by gram-positive organisms
Martin E. Stryjewski et al.
CLINICAL INFECTIOUS DISEASES (2008)
Alternatives to vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections
Scott T. Micek
CLINICAL INFECTIOUS DISEASES (2007)
Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp.
Neil Woodford et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2006)
The PmrA-regulated pmrC gene mediates phosphoethanolamine modification of lipid A and polymyxin resistance in Salmonella enterica
H Lee et al.
JOURNAL OF BACTERIOLOGY (2004)
Recommendations for susceptibility tests on fastidious organisms and those requiring special handling
A King
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2001)
Share Paper
